UNSPSC 51331700: Antipsychotic amides

Antipsychotic drugs made from organic compounds containing the -CO-NH2 radical, derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group.

UNSPSC 51331700 Antipsychotic amides is a Class code that does not align with the state and local procurement activity currently tagged under it. The recent opportunities posted against this code involve naloxone procurement, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer prescription programs—none of which are antipsychotic amides. The mismatch suggests either a data-classification issue or that the code is being used as a catch-all for pharmaceutical product solicitations beyond its nominal scope. The actual buying under these miscoded opportunities spans emergency-response medications (naloxone), generic pharmaceutical distribution through wholesaler networks, and pharmacy benefit program design—work that falls outside the antipsychotic-amide category.

State and local issuing bodies pursuing pharmaceutical-related work include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon). Recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems with a July 26, 2023 response deadline; Texas HHS's RFI on direct-to-manufacturer prescription programs posted April 3, 2026; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, effective July 1, 2026. Geographic activity centers on Florida, Texas, and Minnesota. Prospective vendors should verify the correct UNSPSC classification for pharmaceutical work before pursuing opportunities under this code, as the present tagging does not reflect the products and services actually being solicited.